Its RCM Woes Resolved, Pediatrix Eyes M&A Again
The physician services firm’s leaders expect to wrap up the sales of most of the company’s office-based practices by the end of the year.
Read More
Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses?
Cost effectiveness analyses (CEA) aim to examine how a new health technologies impact health outcomes and costs over a patient’s lifetime. While extrapolating long-run health benefits and measuring potential cost offsets are important, another important item to estimate is how the cost of the new health technology is likely to evolve over times. This is…
5 Interesting Companies I Saw at HLTH
I met a mix of biotech and healthtech companies at HLTH affecting everything from drug development, drug efficacy to controlling specialty care costs and managing chronic diseases. The post 5 Interesting Companies I Saw at HLTH appeared first on MedCity News.
Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs
The Novo Nordisk/Ascendis partnership’s lead program is once-monthly injectable semaglutide for type 2 diabetes and obesity. This product candidate will be developed with Ascendis Pharma technology that has already yielded two FDA-approved products with longer dosing intervals. The post Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs appeared first…
Maryland Begins Planning for CMS AHEAD Model Implementation
Maryland has signed an agreement with CMS on the model, which will seek to improve population health and lower costs.
Is There Still a Place for Point Solutions? One Investor Weighs In
There are some areas where point solutions make a lot of sense, such as when they’re focused on a condition without a lot of comorbidities, according to one healthcare expert. The post Is There Still a Place for Point Solutions? One Investor Weighs In appeared first on MedCity News.
Viking Therapeutics’ Early Clinical Data Continue to Build Case for Its Oral Obesity Drug
Higher doses of a Viking Therapeutics pill that targets two receptors led to greater weight loss without worsening safety or tolerability, according to Phase 1 results presented during the ObesityWeek conference. Meanwhile, an injectable version of this Viking drug is on track to Phase 3 testing. The post Viking Therapeutics’ Early Clinical Data Continue to…
Why AI Governance Is the Number 1 Issue on This Health System Exec’s Mind
Jason Hill, Ochsner Health’s innovation officer, said he goes to sleep most nights and wakes up most morning worried about one thing: the state of generative AI governance in healthcare. To him, providers and other healthcare organizations are in dire need of frameworks to ensure their AI tools are safe and perform well over time….
Patty Hayward, TalkDesk
Patty Hayward is GM of Healthcare and Life Sciences at TalkDesk. TalkDesk runs the technology for contact centers that helps companies across health care connect and manage their consumers. You’ve probably unknowingly used their technology when you call (or now text or email) your health plan, your provider system or call into one of those…
Regresar rápido a la escuela y hacer ejercicio ligero puede ayudar a los niños y jóvenes a recuperarse de conmociones cerebrales
Durante la práctica de porristas en abril, Karter, la hija de Jana Duey que cursa el sexto grado, sufrió una conmoción cerebral cuando cayó de cabeza desde varios pies de altura sobre una colchoneta en el gimnasio. Días después, la joven aún tenía dolor de cabeza, mareos y sensibilidad a la luz y al ruido….